Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY – Get Free Report)’s stock price gapped up before the market opened on Thursday. The stock had previously closed at $10.5440, but opened at $11.0380. Santen Pharmaceutical shares last traded at $10.71, with a volume of 564 shares traded.
Santen Pharmaceutical Stock Down 1.2%
The business has a fifty day moving average of $11.63 and a 200-day moving average of $11.74.
About Santen Pharmaceutical
Santen Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company focused on ophthalmology. The company researches, develops, manufactures and markets prescription ophthalmic medicines and related products used to treat eye diseases and disorders.
Its product portfolio addresses conditions including glaucoma, dry eye disease, retinal diseases, ocular allergies, infections and inflammation. Santen also develops treatments for other serious vision-related conditions and provides products for eye-care professionals and patients.
Founded in 1890 and headquartered in Osaka, Japan, Santen has built a business serving patients and healthcare providers in Japan and international markets, including other parts of Asia, Europe and North America.
Featured Stories
- Five stocks we like better than Santen Pharmaceutical
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
- JPMorgan Bets on Genius Sports as the Market Loses Patience
- Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
- First Watch’s Growth Story Meets a Reality Check
Receive News & Ratings for Santen Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Santen Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
